Therapy Area
Baudax Bio reports promising additional data for neuromuscular blockade agent
Shares rose for the company following data that favourably compares high-dose BX1000 to rocuronium.
ASCO 2023: Moderna and MSD’s vaccine/IO combo reduces chances of melanoma spreading
Oragenics secures CQDM funding for Covid-19 vaccine antigen development
FDA approves INJECTAFER for iron deficiency in heart failure adult patients
ASCO 2023: Summit Therapeutics plans to rise with bispecific NSCLC data
ASCO 2023: Research backs chemo-only approach for some rectal cancer patients
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
